IL18 and macrophage activation syndrome: Conclusion: Our data demonstrate how specific viral insults or IL-1R1 blocking therapy in the context of inflammation can set off the T1IFN-IL-18-IFNγ axis as hallmark of hyperinflammation in MAS.